Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children

Anesthesiology

Volumn 84, Issue 2, 1996, Pages 354-361

  Bevan, Joan C ^a   Tousignant, Claude ^b   Stephenson, Catherine ^b   Blackman, Lee ^b   Reimer, Eleanor ^b   Smith, Michael F ^b   Bevan, David R ^b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b NONE

Author keywords

Anesthesia: adult; pediatric; Antagonists, neuromuscular relaxant: edrophonium; neostigmine; Neuromuscular relaxants: mivacurium

Indexed keywords

EDROPHONIUM; FENTANYL; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; PROPOFOL;

ADULT; AGE; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CHILD; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ANESTHESIA RECOVERY PERIOD; CHILD; CHILD, PRESCHOOL; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDROPHONIUM; HUMANS; INFANT; ISOQUINOLINES; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 0030020493     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199602000-00013     Document Type: Article

References (34)

1. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA: The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): A short-acting nondepolarizing ester neuromuscular blocking drug. ANESTHESIOLOGY 1988; 68:723-32
2. Weber S, Brandom BW, Powers DM, Sarner JB, Woelfel SK, Cook DR, Foster VJ, McNulty BF, Weakly JN: Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients. Anesth Analg 1988; 67:495-9
3. Caldwell JE, Kitts JB, Heier T, Fahey MR, Lynam DP, Miller RD: The dose-response relationship of mivacurium chloride in humans during nitrous oxide-fentanyl or nitrous oxide-entlurane anesthesia. ANESTHESIOLOGY 1989; 70:31-5
4. Choi WW, Mehta MP, Murray DJ, Sokoll MD, Forbes RB, Gergis SD, Abou-Donia M, Kirchner J. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia. Can J Anaesth 1989; 36:641-50
5. Cook DR, Stiller RL, Weakly JN, Chakravorti S, Brandom BW, Welch RM: In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 1989;68:452-6
6. Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN: Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: Comparison with vecuronium and atracurium. Br J Anaesth 1988; 61:541-6
7. Engbæk J, Ørding H, Viby-Mogensen J: Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth 1983; 55:497-500
8. Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ: Neuromuscular and cardiovascular effects of mivacurium in children. ANESTHESIOLOGY 1989; 70:237-42
9. Shanks CA, Fragen RJ, Pemberton D, Katz JA, Risner ME: Mivacurium-induced neuromuscular blockade following single bolus doses and with continuous infusion during either balanced or enflurane anesthesia. ANESTHESIOLOGY 1989; 71:362-6
10. Dicfenbach C, Mellinghoff H, Lynch J, Buzello W: Mivacurium: Dose-response relationship and administration by repeated injection or infusion. Anesth Analg 1992; 74:420-30
11. Baurain MJ, Dcrnovoi BS, d'Hollander AA, Hennart DA: Comparison of neostigmine-induced recovery with spontaneous recovery from mivacurium-induced neuromuscular block. Br J Anaesth 1994; 73:791-4
12. Ding Y, Fredman B, White PF: Use of mivacurium during laparascopic surgery: Effect of reversal drugs on postoperative recovery. Anesth Analg 1994; 78:450-6
13. Naguib M, Abdulatif M, Al-Ghamdi A, Hamo I, Nouheid R: Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Br J Anaesth 1993; 71:709-14
14. Meakin G, Sweet PT, Bevan JC, Bevan DR: Neostigmine and edrophonium as antagonists of pancuronium in infants and children. ANESTHESIOLOGY 1983; 59:316-21
15. Bevan JC, Purday JP, Reimer EJ, Bevan DR: Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children. Can J Anaesth 1994; 41:1074-80
16. Ferguson A, Egerszegi P, Bevan DR: Neostigmine, pyridostigmine, and edrophonium a antagonists of pancuronium. ANESTHESIOLOGY 1980; 53:390-4
17. Koscielniak-Nielsen ZJ, Law-Min JC, Donati F, Bevan DR, Clement P, Wise R: Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients. Anesth Analg 1992; 74:845-50
18. Fisher DM, Cronnelly R, Miller RD, Sharma M: The neuromuscular pharmacology of neostigmine in infants and children. ANESTHESIOLOGY 1983; 59:220-5
19. Fisher DM, Cronnelly R, Sharma M, Miller RD. Clinical pharmacology of edrophonium in infants and children. ANESTHESIOLOGY 1984; 61:428-33
20. Cronnelly R, Morris RB, Miller RD: Edrophonium: Duration of action and atropine requirement during halothane anesthesia. ANESTHESIOLOGY 1982; 57:261-6
21. Miller RD, Van Nyhuis LS, Eger EI II, Vitez TS, Way WL: Comparative times to peak effect and durations of action of neostigmine and pyridostigmine. ANESTHESIOLOGY 1974; 41:27-33
22. Smith CE, Donati F, Bevan DR: Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. ANESTHESIOLOGY 1989; 71:37-43
23. Donati F, McCarroll SM, Antzaka C, McCready D, Bevan DR: Dose response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine. ANESTHESIOLOGY 1987; 66:471-6
24. Abdulatif M: Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block. Br J Anaesth 1995; 74:20-5
25. Kao YJ, Le N, Barker SJ: Neostigmine prolongs profound neuromuscular blockade induced by mivacurium in surgical patients (abstract). ANESTHESIOLOGY 1994; 79:A929
26. Mirakhur RK, Lavery TD, Briggs LP, Clarke RSJ: Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Can Anaesth Soc J 1982; 29:55-8
27. Mirakhur RK: Edrophonium and plasma cholinesterase activity. Can Anaesth Soc J 1986; 33:588-90
28. Szenohradszky J, Lau M, Brown R, Sharma ML, Fisher DM: The effect of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium. ANESTHESIOLOGY 1995; 83:83-7
29. Hart PS, Wright PMC, Brown R, Lau M, Sharma ML, Miller RD, Gruenke L, Fisher DM: Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis. ANESTHESIOLOGY 1995; 82:912-8
30. Matteo RS, Spector S, Horowitz PE: Relation of serum d-tubocurarine concentration to neuromuscular blockade. ANESTHESIOLOGY 1974; 41:44-8
31. Agoston S, Crul JF, Kersten UW, Scaf AH: Relationship of the serum concentration of pancuronium to its neuromuscular activity in man. ANESTHESIOLOGY 1977; 47:509-12
32. Sohn YJ, Bencini AF, Scaf AHJ, Kersten UW, Agoston S: Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients. Anesth Analg 1986; 65:233-9
33. Frambrough DM: Control of acetylcholine receptors in skeletal muscle. Physiol Rev 1979; 59:166-227
34. Kopman AF, Mallhi MU, Justo MD, Rodricks P, Newman GG: Antagonism of mivacurium-induced neuromuscular blockade in humans: Edrophonium dose requirements at threshold train-of-four. ANESTHESIOLOGY 1994; 81:1394-400